Association Between Severe Periodontitis and Arterial Stiffness: The PAROCAR Study
Official title: Evaluation of the Association Between the Effects of Generalized Stage 3 and 4 Periodontitis on Arterial Stiffness and Cardiovascular Risk: the PAROCAR Study
Run by Nantes University Hospital · NCT07263113 · Data updated 2026-11-12
This study tests whether adults with generalized stage 3-4 periodontitis have greater arterial stiffness than healthy adults, to see if severe gum disease links to higher cardiovascular risk.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 69 Years |
| Sex | All |
| Enrollment | 206 (estimated) |
| Sponsor | Nantes University Hospital Academic / other |
| Locations | 1 site (Nantes) |
| Status | Recruiting |
| Started | April 10, 2026 |
| Main results expected | December 1, 2027 |
| Study ends | December 1, 2027 |
| Registry record updated | June 23, 2026 |
| Trial ID | NCT07263113 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 40-69 with at least 12 teeth, including those with generalized stage 3-4 periodontitis according to the 2017 Chicago Classification.
✕Probably not a fit
Individuals with diabetes, hypertension, major cardiovascular disease, BMI ≥ 30, or recent periodontal treatment may not experience direct benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
PAROCAR is a monocentric, prospective cross-sectional study that compares arterial stiffness, measured by pulse wave velocity, between adults with generalized periodontitis stage 3-4 and matched controls without periodontitis. The study enrolls 206 participants aged 40-69, excluding those with diabetes, hypertension, major cardiovascular disease, high BMI, or recent periodontal treatment, among other criteria. Periodontal examinations and PWV measurements are performed to explore potential associations with conventional cardiovascular risk factors. The investigation aims to provide proof of concept for a contributory role of severe periodontitis in cardiovascular risk. Findings may inform future strategies linking oral health and cardiovascular health.
Why it matters
Potential benefit: If successful, the study could support screening and management of periodontal disease as part of cardiovascular risk assessment.
How similar studies have gone: Previous research has suggested links between periodontal inflammation and cardiovascular risk, but this study provides a targeted, cross-sectional assessment of arterial stiffness in a defined severe periodontitis population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 40-69 years * Minimum of 12 teeth (3 per quadrant) * Written informed consent Exposed group: generalized periodontitis stage 3 or 4 (Chicago 2017 Classification) Non-exposed group: healthy periodontium Exclusion Criteria: * Patients diagnosed with diabetes, * Patients diagnosed with hypertension or with a history of severe cardiovascular disease, * Patients diagnosed with familial hypercholesterolaemia, * Patients with a medical history or current condition that, in the investigator's opinion, is likely to interfere with the study results, * Patients with a BMI ≥ 30 kg/m², * Patients who have previously undergone periodontal treatment, * Patients who consume more than 2 units of alcohol per day, * Patients who refuse to participate in the study, * Minors and patients under the age of 40, * Adult patients under legal protection (guardianship, curatorship), * Patients deprived of their liberty, * Pregnant or breastfeeding women, * Patients not affiliated with a health insurance scheme (AME) * Patients already included in another interventional study
Where it's running
-
CHU de Nantes
Nantes, France Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Understanding heart artery disease using biomarkers and imaging in Oxford
Researchers in Oxford are testing how biomarkers and advanced imaging can help explain why some heart artery plaques are unstable and how this affects heart damage after a heart attack.
-
Isometric resistance exercise for atherosclerosis in hypertension
This study tests whether isometric resistance exercise, like wall squats, can improve markers of atherosclerosis in adults with high blood pressure.
-
Single-cell and spatial mapping of cells in gum tissue from aggressive versus chronic periodontitis
This project tests whether single-cell and spatial transcriptomics plus whole-genome sequencing can find cellular and genetic differences in gum tissue from people with aggressive periodontitis compared with chronic periodontitis and healthy gums.
-
How moderate wine drinking affects healthy aging through post-meal extracellular vesicles
This test will see if a single serving of red or white wine changes circulating extracellular vesicles in healthy adults aged 35–65.
-
ABP-745 to reduce atherosclerotic plaque in people with ASCVD
This trial will test whether ABP-745 reduces atherosclerotic plaque over 52 weeks in adults (18–75) with ASCVD who are already taking oral lipid-lowering therapy.
-
Mouth bacteria and carotid artery plaque vulnerability
This project will see if mouth bacteria are linked to vulnerable carotid plaques in adults having carotid endarterectomy at Semmelweis University.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.